Cai et al[37] studied the regulatory mechanism of microRNA-29 in NASH and found that microRNA-29 affected NASH through the IL-17 signaling pathway after acting on FOS. The gene discussed is FOS; the disease is metabolic dysfunction-associated steatohepatitis.